Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VM100 Nutritional Supplement for Quality of Life in DMD
NCT07766980Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, randomised trial in Duchenne muscular dystrophy (DMD), sponsored by University of Florida. Primary endpoints: DMD Quality of Life Physical Symptoms Domain at 10 weeks, Warwick-Edinburgh Mental Well-being Scale at 10 weeks and 1 more. Started Jul 2026; status: recruiting.
02
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT07766980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07766980.